AR and posterior cortical atrophy: Although everolimus in combination with bicalutamide has not been found to be effective in PCa patients (Buckle et al, 2010), our findings suggest that the combination of everolimus with VN/124-1 may be effective in resistant disease, based on the more complete inhibition of AR and mTOR signalling.